These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 5385093

  • 1. [Study on the fibrinolysis in renal hypertension].
    Guseĭnov ChS, Khundadze SSh, Belichenko IA, Smirnova LI, Kurate LV.
    Klin Med (Mosk); 1969 Jul; 47(7):70-5. PubMed ID: 5385093
    [No Abstract] [Full Text] [Related]

  • 2. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K, Prokopowicz J, Gabryelewicz A.
    Haematologia (Budap); 1970 Jul; 4(3):399-403. PubMed ID: 4256949
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Changes of blood coagulation in essential and nephrogenic hypertension].
    Andrushchenko AV, Mironets VI.
    Vrach Delo; 1973 Mar; 3():14-7. PubMed ID: 4733018
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM, MacCarthy EP, Glas-Greenwalt P, Clyne DH, Pollak VE.
    J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555
    [Abstract] [Full Text] [Related]

  • 7. [Fibrinolysis and vascular diseases].
    Udvardy M, Boda Z.
    Orv Hetil; 1996 Aug 25; 137(34):1851-5. PubMed ID: 8927337
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of fibrinolysis in the development of atherothrombosis: role of adipose tissue.
    Juhan-Vague I, Alessi MC.
    Thromb Haemost; 1999 Aug 25; 82(2):832-6. PubMed ID: 10605790
    [No Abstract] [Full Text] [Related]

  • 10. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB, Obrig TG.
    Microvasc Res; 1994 May 25; 47(3):377-87. PubMed ID: 8084301
    [Abstract] [Full Text] [Related]

  • 11. [Clinical value of the measure of global fibrinolytic activity].
    Guillaume M, Zouaoui Boudjeltia K, Cauchie P, Hénuzet C.
    Rev Med Brux; 2001 Apr 25; 22(2):A115-7. PubMed ID: 11388033
    [No Abstract] [Full Text] [Related]

  • 12. [Regulation of plasminogen activation].
    Takada A, Takada Y.
    Rinsho Byori; 1982 Jun 25; Suppl 50():153-66. PubMed ID: 7131806
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of the activity of the fibrinolytic system by means of blood and euglobulin fibrinolysis].
    Januszko T, Górski J, Reutt H.
    Pol Tyg Lek; 1968 May 27; 23(22):818-21. PubMed ID: 5667103
    [No Abstract] [Full Text] [Related]

  • 14. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 27; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 15. [Fibrinolysis incidence in arteriosclerosis-induced illnesses as well as in arteriosclerosis positive and negative syntropic diseases].
    Schulz FH, Bach G, Künzel A.
    Dtsch Gesundheitsw; 1970 Apr 16; 25(15):682-4. PubMed ID: 5483709
    [No Abstract] [Full Text] [Related]

  • 16. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 16; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 17. Betalipoproteins and euglobulin lysis time.
    Cucuianu M.
    Thromb Diath Haemorrh; 1966 Dec 01; 16(3):687-96. PubMed ID: 5996681
    [No Abstract] [Full Text] [Related]

  • 18. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T.
    J Lab Clin Med; 1993 Oct 01; 122(4):412-20. PubMed ID: 8228555
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of plasminogen and other fibrinolytic parameters in the amniotic fluid.
    Aznar J, Gilabert J, Estelles A, Parrilla JJ.
    Thromb Haemost; 1980 Jun 18; 43(2):182. PubMed ID: 7455978
    [No Abstract] [Full Text] [Related]

  • 20. [Prostaglandin F2 alpha and renal hypertension].
    Milanov S, Belovezhdov N, Milkov V, Gurev I, Kiperova B.
    Vutr Boles; 1981 Jun 18; 20(6):54-8. PubMed ID: 6950590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.